Telomerase inhibitors as novel antitumor drugs

2011 ◽  
Vol 47 (7) ◽  
pp. 655-660 ◽  
Author(s):  
A. I. Glukhov ◽  
L. V. Svinareva ◽  
S. E. Severin ◽  
V. I. Shvets
2017 ◽  
Vol 63 (3) ◽  
pp. 497-505
Author(s):  
Vadim Pokrovskiy ◽  
Yelena Lukasheva ◽  
Nikolay Chernov ◽  
Yelena Treshchalina

The effectiveness of L-lysine-alpha oxidase Trichoderma cf. Aureoviride Rifai BKMF-4268D (LO) on models of subcutaneous xenografts of human tumors in athymic mice as well as the effectiveness of combination therapy with known antitumor drugs: cisplatin, irinotecan, etoposide on models of P388 lymphocytic leukemia, Lewis lung (LLC) and B16 melanoma was evaluated. The intraperitoneal injection of LO in a discrete regime at doses of 150-75-75-75-75 E/kg demonstrated inhibition of growth of all studied xenografts of human tumors in athymic mice. The combination of irinotecan+LO on the LLC model gave a significant summative therapeutic benefit with an increase in mouse life expectancy up to 35%. Cisplatin and LO realized a significant (p


2015 ◽  
Vol 16 (10) ◽  
pp. 894-910 ◽  
Author(s):  
Wei-dang Wu ◽  
Xiu-lin Yi ◽  
Li-xin Jiang ◽  
Ya-zhuo Li ◽  
Jing Gao ◽  
...  

2019 ◽  
Vol 42 ◽  
pp. 12-21 ◽  
Author(s):  
Cristina Corno ◽  
Paola Perego
Keyword(s):  

2016 ◽  
Vol 13 (1) ◽  
pp. 49-61 ◽  
Author(s):  
Rakesh R. Somani ◽  
Mayuri H. Patel

2013 ◽  
Vol 29 (3) ◽  
pp. 169-176 ◽  
Author(s):  
V. V. Negrutska ◽  
L. V. Dubey ◽  
M. M. Ilchenko ◽  
I. Ya. Dubey

1982 ◽  
Vol 32 (6) ◽  
pp. 1135-1142 ◽  
Author(s):  
Ken-ichi SASAKI ◽  
Shinobu FURUSAWA ◽  
Giichi TAKAYANAGI

Sign in / Sign up

Export Citation Format

Share Document